Science Explorer Back to mapMap
Discussion
Researcher · Novartis (Switzerland) · Switzerland

Christine M. Fritsch

Christine M. Fritsch publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as PI3K/AKT/mTOR signaling in cancer, Fibroblast Growth Factor Research and Growth Hormone and Insulin-like Growth Factors.

OpenAlex
World rank
#824,572
of 7,710,434 ranked researchers
Rank in Switzerland
#14,466
of 80,918
Works
143
Citations
5k
Citations per work
35.2
h-index
26
i10-index 38Top 20% in Molecular Biology
Christine M. Fritsch

What does Christine M. Fritsch research?

Christine M. Fritsch's work is mostly in Biochemistry, Genetics and Molecular Biology (44%), Medicine (25%).

Life Sciences: 63 works · 44.0% of their workBiochemistry, Genetics and Molecular Biology: 63 works · 44.0% of their workMolecular Biology: 56 works · 39.5% of their workGenetics: 6 works · 4.5% of their workEverything else: 44 works · 31.0% of their workHealth Sciences: 36 works · 25.0% of their workMedicine: 36 works · 25.0% of their workOncology: 14 works · 10.0% of their workPulmonary and Respiratory Medicine: 9 works · 6.5% of their workSurgery: 6 works · 4.5% of their workEndocrinology, Diabetes and Metabolism: 6 works · 4.0% of their workTHEIR WORKChristine M.Fritsch143works
Life Sciences44%Health Sciences25%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology6344.0%
  2. Everything else4431.0%
    1. Medicine3625.0%
  1. 1Molecular Biology40% of their works
  2. 2Oncology10% of their works
  3. 3Pulmonary and Respiratory Medicine6% of their works
  4. 4Genetics4% of their works
  5. 5Surgery4% of their works
  6. 6Endocrinology, Diabetes and Metabolism4% of their works

Research topics

Which keywords describe Christine M. Fritsch's research?

The keywords of their largest research topics: Cancer, Metabolism, Signaling, mTOR, PI3K/AKT pathway, Chronic Lymphocytic Leukemia, FGF21 and Fibroblast Growth Factor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Cancer523 topics
  2. Metabolism523 topics
  3. Signaling442 topics
  4. PI3K/AKT pathway361 topic
  5. mTOR361 topic
  6. Chronic Lymphocytic Leukemia81 topic
  7. FGF2181 topic
  8. Fibroblast Growth Factor81 topic
  9. Genomic Aberrations81 topic
  10. IGF-181 topic
  11. Insulin-like Growth Factors81 topic
  12. Breast Cancer71 topic
  13. CDK4/6 Inhibitors71 topic
  14. Enzyme Regulation71 topic
  15. Genetic Adaptation71 topic
  16. Lactase Persistence71 topic
  17. Nucleotide Metabolism71 topic
  18. Cell Cycle61 topic
  19. p5361 topic

Where does Christine M. Fritsch work?

Christine M. Fritsch's main affiliation in the publication record is Novartis (Switzerland), Switzerland.

How many publications and citations does Christine M. Fritsch have?

OpenAlex counts 143 works and 5,031 citations for Christine M. Fritsch, an h-index of 26, ranking #824,572 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christine M. Fritsch. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.